Tapewire

Nasdaq · USD

BYFC

BROADWAY FINANCIAL CORP DE

Export transactions ↓
Tapewire entity
6703
SEC CIK
0001001171
Parsed reports
195

Last 12 months

Inside the activity.

0 purchase rows · 22 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 2026022
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 24, 2025 Filed Mar 26, 2025 22:46 UTC GrantCommon Stock 2,904 $7.23 $20,995.92
Disclosure

SEC source: 0001140361-25-010507 · form4.xml · nonDerivative · entry 1

Donovan Mary Ann · CIK 0001851769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,548

F1 · shares: Represents Award of Unrestricted stock issued on March 24, 2025 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023.

Read SEC document
March 24, 2025 Filed Mar 26, 2025 22:45 UTC GrantCommon Stock 2,904 $7.23 $20,995.92
Disclosure

SEC source: 0001140361-25-010506 · form4.xml · nonDerivative · entry 1

McGrady David J. · CIK 0001851527 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,548

F1 · shares: Represents Award of Unrestricted stock issued on March 24, 2025 pursuant to the amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023.

Read SEC document
March 24, 2025 Filed Mar 26, 2025 22:44 UTC GrantCommon Stock 2,904 $7.23 $20,995.92
Disclosure

SEC source: 0001140361-25-010504 · form4.xml · nonDerivative · entry 1

DAVIDSON ROBERT C JR · CIK 0001219803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,452

F1 · shares: Represents Award of Unrestricted stock issued on March 24, 2025 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023.

Read SEC document
March 24, 2025 Filed Mar 26, 2025 22:41 UTC GrantCommon Stock 2,904 $7.83 $22,738.32
Disclosure

SEC source: 0001140361-25-010500 · form4.xml · nonDerivative · entry 1

Ross Dutch C. III · CIK 0001668417 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,387

F1 · shares: Represents Award of Unrestricted stock issued on March 24, 2025 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023.

Read SEC document
March 24, 2025 Filed Mar 26, 2025 22:41 UTC
Argrett Brian EDirector · President/CEO
GrantCommon Stock 21,368 $7.23 $154,490.64
Disclosure

SEC source: 0001140361-25-010497 · form4.xml · nonDerivative · entry 1

Argrett Brian E · CIK 0001361104 · Director · President/CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,959

F1 · shares: Restricted Stock granted March 24, 2025, which shall vest as follows: to the extent of thirty-three percent (33%) of the shares covered thereby on the first anniversary of the date of grant, with the balance vesting ratably over the succeeding twenty-four (24) months.

F2 · balance_after: Shares amount adjusted for reverse stock split effective October 31, 2023.

Read SEC document
March 24, 2025 Filed Mar 26, 2025 22:40 UTC GrantCommon Stock 5,498 $7.23 $39,750.54
Disclosure

SEC source: 0001140361-25-010495 · form4.xml · nonDerivative · entry 1

McCloud Ruth · CIK 0001616797 · EVP/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,108

F1 · shares: Restricted Stock granted March 24, 2025 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

F2 · balance_after: Shares amount adjusted for reverse Stock split effective October 31, 2023

Read SEC document
March 24, 2025 Filed Mar 26, 2025 22:40 UTC GrantCommon Stock 2,904 $7.23 $20,995.92
Disclosure

SEC source: 0001140361-25-010494 · form4.xml · nonDerivative · entry 1

LONGBRAKE WILLIAM A · CIK 0001057032 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,048

F1 · shares: Represents Award of Unrestricted stock issued on March 24, 2025 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31,2023

Read SEC document
March 24, 2025 Filed Mar 26, 2025 22:37 UTC
Ibrahim ZackEVP, Chief Financial Officer
GrantCommon Stock 8,101 $7.23 $58,570.23
Disclosure

SEC source: 0001140361-25-010491 · form4.xml · nonDerivative · entry 1

Ibrahim Zack · CIK 0002024462 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,746

F1 · shares: Restricted Stock granted March 24, 2025 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

Read SEC document
March 24, 2025 Filed Mar 26, 2025 22:37 UTC GrantCommon Stock 2,904 $7.23 $20,995.92
Disclosure

SEC source: 0001140361-25-010490 · form4.xml · nonDerivative · entry 1

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,864

F1 · shares: Represents Award of Unrestricted stock issued on March 24, 2025 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
March 24, 2025 Filed Mar 26, 2025 22:20 UTC
Tellenbach John FrederickEVP, W. Commercial Reg. Exec.
GrantCommon Stock 4,928 $7.23 $35,629.44
Disclosure

SEC source: 0001140361-25-010477 · form4.xml · nonDerivative · entry 1

Tellenbach John Frederick · CIK 0001970906 · EVP, W. Commercial Reg. Exec.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,226

F1 · shares: Restricted Stock granted March 24, 2025 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term incentive Plan effective April 16, 2023.

Read SEC document
March 24, 2025 Filed Mar 26, 2025 22:33 UTC GrantCommon Stock 2,904 $7.23 $20,995.92
Disclosure

SEC source: 0001140361-25-010483 · form4.xml · nonDerivative · entry 1

JOHNS MARIE C · CIK 0001108201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,548

F1 · shares: Represents Award of Unrestricted stock issued on March 24, 2025 pursuant to the amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023.

Read SEC document
March 24, 2025 Filed Mar 26, 2025 22:14 UTC
Wells Sonja SandersEVP/E. Commercial Reg. Exec
GrantCommon Stock 5,359 $7.23 $38,745.57
Disclosure

SEC source: 0001140361-25-010470 · form4.xml · nonDerivative · entry 1

Wells Sonja Sanders · CIK 0001851521 · EVP/E. Commercial Reg. Exec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,622

F1 · shares: Restricted Stock granted March 24, 2025 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

F2 · balance_after: Shares amount adjusted for reverse stock split effective October 31, 2023.

Read SEC document
March 24, 2025 Filed Mar 26, 2025 22:14 UTC
Driver JohnDirector
GrantCommon Stock 2,904 $7.23 $20,995.92
Disclosure

SEC source: 0001140361-25-010469 · form4.xml · nonDerivative · entry 1

Driver John · CIK 0001930914 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,536

F1 · shares: Represents Award of Unrestricted stock issued on March 24, 2025 pursuant to the amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023.

Read SEC document
March 24, 2025 Filed Mar 26, 2025 22:10 UTC
Washington LaShanya DemetriceEVP, Chief Credit Officer
GrantCommon Stock 4,879 $7.23 $35,275.17
Disclosure

SEC source: 0001140361-25-010466 · form4.xml · nonDerivative · entry 1

Washington LaShanya Demetrice · CIK 0001970473 · EVP, Chief Credit Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,820

F1 · shares: Restricted Stock granted March 24, 2025 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

F2 · balance_after: Shares Amount adjusted for Reverse Stock split effective October 31, 2023.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 16:52 UTC SaleCommon Stock 445 $7.80 $3,468.78
Disclosure

SEC source: 0001140361-25-002952 · form4.xml · nonDerivative · entry 1

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,780

F1 · balance_after: Item 5. The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 22, 2024 Filed May 24, 2024 01:15 UTC GrantCommon Stock 2,479 $4.84 $11,998.36
Disclosure

SEC source: 0001140361-24-027351 · form4.xml · nonDerivative · entry 1

JOHNS MARIE C · CIK 0001108201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,644

F1 · shares: Represents Award of Unrestricted stock issued on May 22, 2024 pursuant to the amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023.

Read SEC document
May 22, 2024 Filed May 24, 2024 01:15 UTC
Driver JohnDirector
GrantCommon Stock 2,479 $4.84 $11,998.36
Disclosure

SEC source: 0001140361-24-027350 · form4.xml · nonDerivative · entry 1

Driver John · CIK 0001930914 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,632

F1 · shares: Represents Award of Unrestricted stock issued on May 22, 2024 pursuant to the amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023.

Read SEC document
May 22, 2024 Filed May 24, 2024 01:15 UTC GrantCommon Stock 2,479 $4.84 $11,998.36
Disclosure

SEC source: 0001140361-24-027349 · form4.xml · nonDerivative · entry 1

Ross Dutch C. III · CIK 0001668417 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,483

F1 · shares: Represents Award of Unrestricted stock issued on May 22, 2024 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023.

Read SEC document
May 22, 2024 Filed May 24, 2024 01:15 UTC GrantCommon Stock 2,479 $4.84 $11,998.36
Disclosure

SEC source: 0001140361-24-027352 · form4.xml · nonDerivative · entry 1

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,225

F1 · shares: Represents Award of Unrestricted stock issued on May 22, 2024 pursuant to the amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: Item 5. The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 22, 2024 Filed May 24, 2024 01:15 UTC GrantCommon Stock 2,479 $4.84 $11,998.36
Disclosure

SEC source: 0001140361-24-027348 · form4.xml · nonDerivative · entry 1

LONGBRAKE WILLIAM A · CIK 0001057032 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,144

F1 · shares: Represents Award of Unrestricted stock issued on May 22, 2024 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31,2023

Read SEC document
May 22, 2024 Filed May 24, 2024 01:15 UTC GrantCommon Stock 2,479 $4.84 $11,998.36
Disclosure

SEC source: 0001140361-24-027346 · form4.xml · nonDerivative · entry 1

Donovan Mary Ann · CIK 0001851769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,644

F1 · shares: Represents Award of Unrestricted stock issued on May 22, 2024 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023.

Read SEC document
May 22, 2024 Filed May 24, 2024 01:14 UTC GrantCommon Stock 2,479 $4.84 $11,998.36
Disclosure

SEC source: 0001140361-24-027347 · form4.xml · nonDerivative · entry 1

DAVIDSON ROBERT C JR · CIK 0001219803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,548

F1 · shares: Represents Award of Unrestricted stock issued on May 22, 2024 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023.

Read SEC document
May 22, 2024 Filed May 24, 2024 01:14 UTC GrantCommon Stock 2,479 $4.84 $11,998.36
Disclosure

SEC source: 0001140361-24-027345 · form4.xml · nonDerivative · entry 1

McGrady David J. · CIK 0001851527 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,644

F1 · shares: Represents Award of Unrestricted stock issued on May 22, 2024 pursuant to the amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023.

Read SEC document
March 26, 2024 Filed Mar 29, 2024 01:11 UTC
Battey Brenda JEVP/Chief Financial Officer
GrantCommon Stock 7,371 $5.95 $43,857.45
Disclosure

SEC source: 0001140361-24-016366 · form4.xml · nonDerivative · entry 1

Battey Brenda J · CIK 0001578226 · EVP/Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,365

F1 · shares: Restricted Stock granted March 26, 2024 with a 5 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

F2 · balance_after: Shares amount adjusted for Reverse Stock Split effective October 31, 2023.

Read SEC document
March 26, 2024 Filed Mar 29, 2024 00:06 UTC
Argrett Brian EDirector · President/CEO
GrantCommon Stock 25,743 $5.95 $153,170.85
Disclosure

SEC source: 0001140361-24-016342 · form4.xml · nonDerivative · entry 1

Argrett Brian E · CIK 0001361104 · Director · President/CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,591

F1 · shares: Restricted Stock granted March 26, 2024, which shall vest as follows: to the extent of thirty-three percent (33%) of the shares covered thereby on the first anniversary of the date of grant, with the balance vesting ratably over the succeeding twenty-four (24) months.

F2 · balance_after: Shares amount adjusted for reverse stock split effective October 31, 2023.

Read SEC document
March 26, 2024 Filed Mar 29, 2024 00:06 UTC
Tellenbach John FrederickEVP, W. Commercial Reg. Exec.
GrantCommon Stock 5,298 $5.95 $31,523.10
Disclosure

SEC source: 0001140361-24-016340 · form4.xml · nonDerivative · entry 1

Tellenbach John Frederick · CIK 0001970906 · EVP, W. Commercial Reg. Exec.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,298

F1 · shares: Restricted Stock granted March 26, 2024 with a 5 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term incentive Plan effective April 16, 2023.

Read SEC document
March 26, 2024 Filed Mar 29, 2024 00:06 UTC GrantCommon Stock 7,163 $5.95 $42,619.85
Disclosure

SEC source: 0001140361-24-016341 · form4.xml · nonDerivative · entry 1

McCloud Ruth · CIK 0001616797 · EVP/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,610

F1 · shares: Restricted Stock granted March 26, 2024 with a 5 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

F2 · balance_after: Shares amount adjusted for reverse Stock split effective October 31, 2023

Read SEC document
March 26, 2024 Filed Mar 29, 2024 00:06 UTC
Washington LaShanya DemetriceEVP, Chief Credit Officer
GrantCommon Stock 6,387 $5.95 $38,002.65
Disclosure

SEC source: 0001140361-24-016339 · form4.xml · nonDerivative · entry 1

Washington LaShanya Demetrice · CIK 0001970473 · EVP, Chief Credit Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,941

F1 · shares: Restricted Stock granted March 26, 2024 with a 5 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

F2 · balance_after: Shares Amount adjusted for Reverse Stock split effective October 31, 2023.

Read SEC document
March 26, 2024 Filed Mar 29, 2024 00:06 UTC
Wells Sonja SandersEVP/E. Commercial Reg. Exec
GrantCommon Stock 7,970 $5.95 $47,421.50
Disclosure

SEC source: 0001140361-24-016338 · form4.xml · nonDerivative · entry 1

Wells Sonja Sanders · CIK 0001851521 · EVP/E. Commercial Reg. Exec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,263

F1 · shares: Restricted Stock granted March 26, 2024 with a 5 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

F2 · balance_after: Shares amount adjusted for reverse stock split effective October 31, 2023.

Read SEC document
June 21, 2023 Filed Jun 23, 2023 20:29 UTC
Nida Thomas AndrewEVP, Market Executive
GrantCommon Stock 45,885 $1.07 $49,096.95
Disclosure

SEC source: 0001140361-23-031255 · form4.xml · nonDerivative · entry 1

Nida Thomas Andrew · CIK 0001851519 · EVP, Market Executive

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,489

F1 · shares: Restricted Stock granted June 21, 2023 with a 5 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long - Term Incentive Plan effective April 16,2023.

F2 · balance_after: Restricted stock granted March 16, 2022 with a 5 year vesting, prior to meeting guidelines as an senior executive officer.

Read SEC document
June 21, 2023 Filed Jun 24, 2023 00:29 UTC
Wells Sonja SandersEVP/E. Commercial Reg. Exec
GrantCommon Stock 66,310 $1.07 $70,951.70
Disclosure

SEC source: 0001140361-23-031257 · form4.xml · nonDerivative · entry 1

Wells Sonja Sanders · CIK 0001851521 · EVP/E. Commercial Reg. Exec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,349

F1 · shares: Restricted Stock granted June 21, 2023 with a 5 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long -Term incentive Plan effective April 16, 2023.

Read SEC document
June 21, 2023 Filed Jun 24, 2023 00:29 UTC
Battey Brenda JEVP/Chief Financial Officer
GrantCommon Stock 70,361 $1.07 $75,286.27
Disclosure

SEC source: 0001140361-23-031256 · form4.xml · nonDerivative · entry 1

Battey Brenda J · CIK 0001578226 · EVP/Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,956

F1 · shares: Restricted Stock granted June 21, 2023 with a 5 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

Read SEC document
June 21, 2023 Filed Jun 24, 2023 00:29 UTC
Washington LaShanya DemetriceEVP, Chief Credit Officer
GrantCommon Stock 29,799 $1.07 $31,884.93
Disclosure

SEC source: 0001140361-23-031253 · form4.xml · nonDerivative · entry 1

Washington LaShanya Demetrice · CIK 0001970473 · EVP, Chief Credit Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,432

F1 · shares: Restricted Stock granted June 21, 2023 with a 5 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

F2 · balance_after: Includes 6,633 shares awarded March 16, 2022, prior to becoming a senior executive officer.

Read SEC document
June 21, 2023 Filed Jun 24, 2023 00:29 UTC GrantCommon Stock 68,912 $1.07 $73,735.84
Disclosure

SEC source: 0001140361-23-031254 · form4.xml · nonDerivative · entry 1

McCloud Ruth · CIK 0001616797 · EVP/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,582

F1 · shares: Restricted Stock granted June 21, 2023 with a 5 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

Read SEC document
June 21, 2023 Filed Jun 24, 2023 00:29 UTC
Argrett Brian EDirector · President/CEO
GrantCommon Stock 257,009 $1.07 $274,999.63
Disclosure

SEC source: 0001140361-23-031252 · form4.xml · nonDerivative · entry 1

Argrett Brian E · CIK 0001361104 · Director · President/CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 438,787

F1 · shares: Restricted Stock granted June 21,2023, which shall vest as follows: to the extent of thirty-three percent (33%) of the shares covered thereby on the first anniversary of the date of grant, with the balance vesting ratably over the succeeding twenty-four (24) months.

Read SEC document
March 13, 2023 Filed Mar 15, 2023 18:17 UTC PurchaseCommon Stock 2,500 $0.98 $2,443.50
Disclosure

SEC source: 0001567619-23-005092 · doc1.xml · nonDerivative · entry 1

LONGBRAKE WILLIAM A · CIK 0001057032 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,333

F1 · shares: On March 13, 2023 the filer reported a purchase of 2,500 shares of Class A Common Stock.

Read SEC document
March 10, 2023 Filed Mar 13, 2023 14:40 UTC PurchaseCommon Stock 7,500 $1.18 $8,847.75
Disclosure

SEC source: 0001567619-23-004875 · doc1.xml · nonDerivative · entry 1

LONGBRAKE WILLIAM A · CIK 0001057032 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,833

F1 · shares: On March 10, 2023 the filer reported a purchase of 7,500 shares of Class A Common Stock.

Read SEC document
February 21, 2023 Filed Feb 22, 2023 23:02 UTC GrantCommon Stock 9,230 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003551 · doc1.xml · nonDerivative · entry 1

DAVIDSON ROBERT C JR · CIK 0001219803 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,561

F1 · shares: Represents Award of Unrestricted stock issued on February 21, 2023 pursuant to the 2018 Long Term Incentive Plan of Broadway Financial Corporation.

Read SEC document
February 21, 2023 Filed Feb 22, 2023 23:00 UTC GrantCommon Stock 9,230 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003550 · doc1.xml · nonDerivative · entry 1

JOHNS MARIE C · CIK 0001108201 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,333

F1 · shares: Represents Award of Unrestricted stock issued on February 21, 2023 pursuant to the 2018 Long Term Incentive Plan of Broadway Financial Corporation.

Read SEC document
February 21, 2023 Filed Feb 22, 2023 22:40 UTC GrantCommon Stock 9,230 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003548 · doc1.xml · nonDerivative · entry 1

Ross Dutch C. III · CIK 0001668417 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,043

F1 · shares: Represents Award of Unrestricted stock issued on February 21, 2023 pursuant to the 2018 Long Term Incentive Plan of Broadway Financial Corporation.

Read SEC document
February 21, 2023 Filed Feb 22, 2023 21:57 UTC GrantCommon Stock 9,230 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003526 · doc1.xml · nonDerivative · entry 1

McGrady David J. · CIK 0001851527 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,333

F1 · shares: Represents Award of Unrestricted stock issued on February 21, 2023 pursuant to the 2018 Long Term Incentive Plan of Broadway Financial Corporation.

Read SEC document
February 21, 2023 Filed Feb 22, 2023 21:36 UTC Amendment GrantCommon Stock 9,230 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003507 · doc1.xml · nonDerivative · entry 1

LONGBRAKE WILLIAM A · CIK 0001057032 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,333

F2 · shares: Represents Award of unrestricted stock issued on February 21, 2023 pursuant to the 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F1 · balance_after: Form 4/A corrects Item 5. Amount of Securities Beneficially Owned Following Reported Transaction(s). The amount previously reported on Form 4 on February 22, 2023 was 17,333 shares. The correct amount is 67,333 shares.

Read SEC document
February 21, 2023 Filed Feb 22, 2023 20:56 UTC GrantCommon Stock 9,230 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003488 · doc1.xml · nonDerivative · entry 1

LONGBRAKE WILLIAM A · CIK 0001057032 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,333

F1 · shares: Represents Award of Unrestricted stock issued on February 21, 2023 pursuant to the 2018 Long Term Incentive Plan of Broadway Financial Corporation.

Read SEC document
February 21, 2023 Filed Feb 22, 2023 20:51 UTC
Driver JohnDirector
GrantCommon Stock 9,230 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003482 · doc1.xml · nonDerivative · entry 1

Driver John · CIK 0001930914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,230

F1 · shares: Represents Award of Unrestricted stock issued on February 21, 2023 pursuant to the 2018 Long Term Incentive Plan of Broadway Financial Corporation.

Read SEC document
February 21, 2023 Filed Feb 22, 2023 20:44 UTC GrantCommon Stock 9,230 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003480 · doc1.xml · nonDerivative · entry 1

Donovan Mary Ann · CIK 0001851769 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,333

F1 · deemedExecutionDate: Represents Award of Unrestricted stock issued on February 21, 2023 pursuant to the 2018 Long Term Incentive Plan of Broadway Financial Corporation.

Read SEC document
February 21, 2023 Filed Feb 23, 2023 18:05 UTC GrantCommon Stock 9,230 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003585 · doc1.xml · nonDerivative · entry 1

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 244,243

F1 · shares: Represents Award of Unrestricted stock issued on February 21, 2023 pursuant to the 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: Item 5. Withholding of 81,965 shares of Class A Common Stock to satisfy tax withholding obligation.

Read SEC document
March 16, 2022 Filed Mar 18, 2022 21:29 UTC GrantCommon Stock 50,000 $1.55 $77,640.00
Disclosure

SEC source: 0001567619-22-007233 · doc1.xml · nonDerivative · entry 1

LONGBRAKE WILLIAM A · CIK 0001057032 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,103

F1 · shares: On March 17, 2022 the filer reported a purchase of 50,000 shares of Class A Common Stock.

Read SEC document
March 16, 2022 Filed Mar 18, 2022 20:55 UTC GrantCommon Stock 34,444 $1.53 $52,699.32
Disclosure

SEC source: 0001567619-22-007221 · doc1.xml · nonDerivative · entry 1

McCloud Ruth · CIK 0001616797 · EVP/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,670

F1 · shares: Restricted Stock granted March 16, 2022 with a 5 year vesting.

F2 · balance_after: On February 26, 2020 the filer reported an ownership of 46,384 shares. The number above reflects the grant made on March 16, 2022 less withholding of shares that occurred on February 27, 2021 and April 1, 2021 to satisfy tax withholding obligations in connection with the vesting of prior equity awards, which withholding transactions have not previously been reported.

Read SEC document
March 16, 2022 Filed Mar 18, 2022 20:50 UTC
Battey Brenda JEVP/Chief Financial Officer
GrantCommon Stock 40,457 $1.53 $61,899.21
Disclosure

SEC source: 0001567619-22-007218 · doc1.xml · nonDerivative · entry 1

Battey Brenda J · CIK 0001578226 · EVP/Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,595

F1 · shares: Restricted Stock granted March 16, 2022 with a 5 year vesting.

F2 · balance_after: On February 26, 2020 the filer reported an ownership of 54,437 shares. The number above reflects the grant made on March 16, 2022 less withholding of shares that occurred on February 27, 2021 and April 1, 2021 to satisfy tax withholding obligations in connection with the vesting of prior equity awards, which withholding transactions have not previously been reported.

Read SEC document
March 16, 2022 Filed Mar 18, 2022 19:27 UTC
Argrett Brian EPresident/CEO
GrantCommon Stock 137,254 $1.53 $209,998.62
Disclosure

SEC source: 0001567619-22-007208 · doc1.xml · nonDerivative · entry 1

Argrett Brian E · CIK 0001361104 · President/CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,778

F1 · shares: Restricted Stock granted March 16, 2022, which shall vest as follows: to the extent of thirty-three percent (33%) of the shares covered thereby on the first anniversary of the date of grant, with the balance vesting ratably over the succeeding twenty-four (24) months.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.